The predictive ability of plasma ESR1 mutations for the efficacy of endocrine therapy in hormone-receptor-positive advanced breast cancer

PURPOSE: The predictive ability of plasma ESR1 mutations for outcomes among patients with advanced breast cancer undergoing endocrine therapy (ET) remains disputable. We performed a comprehensive meta-analysis of published studies to clarify the impact of plasma ESR1 mutations on clinical outcomes f...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Yangfan, Li, Na, Jiao, Xin, Li, Kai, Yan, Shunchao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6157996/
https://www.ncbi.nlm.nih.gov/pubmed/30275706
http://dx.doi.org/10.2147/OTT.S171465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6157996/
https://www.ncbi.nlm.nih.gov/pubmed/30275706
http://dx.doi.org/10.2147/OTT.S171465

Ejemplares similares